Naoya Kojima

Naoya Kojima

Auto-generated profile, based on publicly available information

Naoya Kojima

Department of Applied Biochemistry, Tokai University, Hiratsuka, Japan

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2016 in Nature Communications
Verified
Journal Article
Open access
TUTomofumi Uto
Tomofumi Uto
TFTomohiro Fukaya
Tomohiro Fukaya
HTHideaki Takagi
Hideaki Takagi
KAKeiichi Arimura
Keiichi Arimura
TNTakeshi Nakamura
Takeshi Nakamura
KSKatsuaki Sato
Katsuaki Sato
Dendritic cells (DCs) comprise several subsets that are critically involved in the initiation and regulation of immunity. Clec4A4/DC immunoreceptor 2 (DCIR2) is a C-type lectin receptor (CLR) exclusively expressed on CD8α− conventional DCs (cDCs). However, how Clec4A4 controls immune responses through regulation of the function of CD8α− cDCs remains unclear. Here we show that Clec4A4 is a regulatory receptor for the activation of CD8α− cDCs that impairs inflammation and T-cell immunity. Clec4a4−/−CD8α− cDCs show enhanced cytokine production and T-cell priming following Toll-like receptor (TLR)-mediated activation. Furthermore, Clec4a4−/− mice exhibit TLR-mediated hyperinflammation. On antigenic immunization, Clec4a4−/− mice show not only augmented T-cell responses but also progressive autoimmune pathogenesis. Conversely, Clec4a4−/− mice exhibit resistance to microbial infection, accompanied by enhanced T-cell responses against microbes. Thus, our findings highlight roles of Clec4A4 in regulation of the function of CD8α− cDCs for control of the magnitude and quality of immune response.

1 July 2008 in Journal of Controlled Release
Verified
Journal Article
Closed access
NKNaoya Kojima
Naoya Kojima
LBLe Biao
Le Biao
TNTomoko Nakayama
Tomoko Nakayama
MIMariko Ishii
Mariko Ishii
YIYuzuru Ikehara
Yuzuru Ikehara
KTKunio Tsujimura
Kunio Tsujimura

10 April 2007 in Parasite Immunology
Verified
Journal Article
Closed access
PDF file
YSY. Shimizu
Y. Shimizu
HTH. Takagi
H. Takagi
TNT. Nakayama
T. Nakayama
KYK. Yamakami
K. Yamakami
TTT. Tadakuma
T. Tadakuma
NKN. Kojima
N. Kojima

4 March 2003 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
YSYoshitaka Shimizu
Yoshitaka Shimizu
KYKazuo Yamakami
Kazuo Yamakami
TGTakao Gomi
Takao Gomi
MNMunehiro Nakata
Munehiro Nakata
HAHideki Asanuma
Hideki Asanuma
NKNaoya Kojima
Naoya Kojima

12 November 2008 in Glycobiology
Verified
Journal Article
Open access
PDF file
HTHideaki Takagi
Hideaki Takagi
MNMaki Numazaki
Maki Numazaki
TKToshimitsu Kajiwara
Toshimitsu Kajiwara
YAY. Abe
Y. Abe
MIMariko Ishii
Mariko Ishii
NKNaoya Kojima
Naoya Kojima
Resident peritoneal macrophages (PEMs) express SIGNR1 on the cell surface as a major mannose receptor. These cells also ingest oligomannose-coated liposomes (OMLs) in an oligomannose-dependent manner following intraperitoneal administration. Therefore, the current study was conducted to investigate the possible role of SIGNR1 in capture of OMLs. Transient expression of several SIGN-related lectins potentially expressed on PEMs in CHO cells revealed that only SIGNR1 contributed to capture of OMLs. When SIGNR1 was introduced into mouse macrophage-like RAW264.7 cells, SIGNR1-expressing RAW (RAW-SIGNR1) cells recognized OMLs under serum-free conditions. OML recognition by RAW-SIGNR1 cells as well as that by PEMs was partially inhibited by an anti-SIGNR1 antibody (ER-TR9) and by mannan, and completely inhibited by EDTA. Interestingly, OML recognition by RAW-SIGNR1 cells was accelerated in the presence of serum, partially inhibited by an anti-complement receptor 3 (CR3) antibody (M1/70), and almost completely inhibited by a combination of ER-TR9 and M1/70. Complete inhibition of OML ingestion by the combination of ER-TR9 and M1/70 was also observed under serum-free conditions, suggesting that SIGNR1 and CR3 cooperate in an additive way in capture of OMLs by macrophage-like RAW cells. Administration of ER-TR9 or M1/70 into the peritoneal cavity led to a significant decrease of OML uptake by PEMs. Therefore, SIGNR1 expressed on macrophages acts as a receptor for recognition of OMLs under physiological conditions.

9 October 2009 in Glycoconjugate Journal
Verified
Journal Article
Closed access
PDF file
MIMariko Ishii
Mariko Ishii
NKNaoya Kojima
Naoya Kojima